XENON PHARMACEUTICALS INC
XENON PHARMACEUTICALS INC
Aktie · CA98420N1050 · XENE · A12ETN (XNMS)
Übersicht Finanzkennzahlen
31,64 USD
2,96 % 0,91 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 20:00

Aktuelle Kurse von XENON PHARMACEUTICALS INC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
XENE
USD
06.06.2025 20:00
31,64 USD
30,73 USD
+2,96 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 9,67 % -10,06 % -15,20 % -25,94 % -16,36 % 167,46 %

Firmenprofil zu XENON PHARMACEUTICALS INC Aktie

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other potential indications, including adult focal epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop PCRX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

Investierte Fonds

Folgende Fonds haben in investiert: XENON PHARMACEUTICALS INC investiert:

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in Mio
25,16
Anteil (%)
0,06 %

Unternehmensdaten

Name XENON PHARMACEUTICALS INC
Firma Xenon Pharmaceuticals Inc.
Symbol XENE
Website https://www.xenon-pharma.com
Heimatbörse XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A12ETN
ISIN CA98420N1050
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.
Marktkapitalisierung 3 Mrd.
Land Kanada
Währung USD
Mitarbeiter 0,3 T
Adresse 3650 Gilmore Way, V5G 4W8 Burnaby
IPO Datum 2014-11-05

Ticker Symbole

Name Symbol
Frankfurt XP0.F
NASDAQ XENE

Weitere Aktien

Investoren die XENON PHARMACEUTICALS INC die halten, haben auch folgende Aktien im Depot:
3M CO 16/31 MTN F
3M CO 16/31 MTN F Anleihe
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
ELECTRONIC ARTS INC
ELECTRONIC ARTS INC Aktie
GS FDS-G.S.EUR.CO.EQ.R EO
GS FDS-G.S.EUR.CO.EQ.R EO Fonds
INTEL CORP
INTEL CORP Aktie
IPATH US TREASURY 5 YEAR BEAR ETN
IPATH US TREASURY 5 YEAR BEAR ETN Aktie
JPMORGAN CHASE & CO
JPMORGAN CHASE & CO Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
NXP SEMICONDUCTORS NV
NXP SEMICONDUCTORS NV Aktie
TENCENT HLDGS SDRS /-,10
TENCENT HLDGS SDRS /-,10 Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025